Analysis
Earnings Preview: Lowe’s (LOW) projected to report higher revenue and earnings for Q4 2025
Shares of Lowe’s Companies, Inc. (NYSE: LOW) dropped 2% on Tuesday. The stock has gained 24% over the...
ADVERTISEMENT
Analysis
Expert equity analysis, earnings previews, and data-driven market research.
Latest Research
2,197 articles
Analysis
Orion Engineered Carbons Confronts Cycle Lows With Cost Reset and Disciplined 2026 Outlook
Orion Engineered Carbons S.A. (NYSE: OEC) is a Luxembourg-based global supplier of specialty and rubber carbon black serving...
Analysis
MITT Solidifies Market Position with Arc Home Expansion and Disciplined Securitization
TPG Mortgage Investment Trust, Inc. (NYSE: MITT), with a market capitalization of approximately $0.29 billion, is a residential mortgage...
Analysis
Energy Transfer LP Announces Record Full-Year 2025 Results and Increased 2026 Guidance
Energy Transfer LP (NYSE: ET) today reported financial and operational results for the fourth quarter and fiscal year...
Analysis
DFIN’s Software Pivot Pays Off: High Margins and Recurring Revenue Lead the Way
Donnelley Financial Solutions Inc (NYSE: DFIN), a provider of regulatory compliance, financial technology, and risk management solutions, had...
Analysis
Cardiovascular and Robotics Drive Medtronic’s Record 10-Quarter Revenue Spike
Medtronic PLC (NYSE: MDT) is a Dublin-based global medical technology company with a market capitalization of approximately $110...
Analysis
CNH Industrial Beats Q4 Estimates but Braces for 2026 Industry Trough
CNH Industrial NV (NYSE: CNH) reported fourth-quarter 2025 financial results on Tuesday that exceeded Wall Street expectations, driven...
Analysis
Tower Semiconductor Q4 2025 Drives Record Revenue and Aggressive CapEx Expansion
Tower Semiconductor (NASDAQ: TSEM, TASE: TSEM) delivered a standout performance for the fourth quarter ended December 31, 2025,...
Analysis
NeoGenomics Full Year 2025 Revenue Rises to $727 Million
NeoGenomics, Inc. (Nasdaq: NEO) shares declined 5.27% in Tuesday’s trading session following the release of its fourth quarter...
Analysis
Krystal Biotech Surpasses Expectations as VYJUVEK Drives Record 2025 Revenue and International Expansion
Krystal Biotech, Inc. (NASDAQ: KRYS), a leader in redosable gene therapies, today announced record-breaking financial results for the...
Analysis
Ceragon Full year 2025 Revenue Totals $338.7 million
Ceragon Networks Ltd. (Nasdaq: CRNT) shares declined 7.30% in Tuesday’s trading session following the release of its fourth-quarter...
Analysis
Hillman Solutions Corp. Reports Record 2025 Revenue Despite Q4 Sales Miss
Hillman Solutions Corp. (Nasdaq: HLMN), a prominent provider of hardware-related products and merchandising solutions, released its fourth-quarter and...